Company Filing History:
1 out of 832,912 Years Active: 2011
Title: Petra Hofmann: Innovator in Immunomodulating Pharmaceutical Compositions
Introduction
Petra Hofmann is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of immunology through her innovative research and patenting activities. Her work focuses on the development of pharmaceutical compositions that leverage the unique properties of fetal hemoglobin and bacterial endotoxin.
Latest Patents
Hofmann holds a patent for her invention titled "Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components." This patent describes a novel immunomodulating principle that combines bacterial endotoxin with fetal hemoglobin or its heme-free derivatives. The composition is designed to be delivered to humans in a pharmaceutically acceptable carrier and/or diluent. Remarkably, it has been found that the combination of endotoxin and fetal hemoglobin exhibits a pronounced synergistic biomedical activity. This activity is not related to the classical function of hemoglobin as an oxygen transporter but rather to the modulation of endotoxin-mediated bioactivity. The composition has potential applications in treating allergic conditions, malignancies, chronic infections, autoimmune phenomena, and age-related imbalances.
Career Highlights
Throughout her career, Petra Hofmann has demonstrated a commitment to advancing biomedical research. Her innovative approach to immunomodulation has positioned her as a key figure in her field. With a focus on the biomedical effects of fetal hemoglobin, she has contributed to a deeper understanding of immune system stimulation and cytokine response modulation.
Collaborations
Hofmann has collaborated with notable individuals in her field, including Otto Westphal and Josette Westphal, who serves as her legal representative. These collaborations have further enhanced her research and development efforts.
Conclusion
Petra Hofmann's work in developing immunomodulating pharmaceutical compositions represents a significant advancement in biomedical research. Her innovative approach and dedication to her field continue to inspire future developments in immunology.